Neurocrine Biosciences
NBIX
#1647
Rank
NZ$22.27 B
Marketcap
NZ$221.45
Share price
-0.79%
Change (1 day)
29.56%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

We have found no dividend yield history for this company